Old Web
English
Sign In
Acemap
>
authorDetail
>
Ojesh R Upadhyay
Ojesh R Upadhyay
GlaxoSmithKline
Cabotegravir
long acting
Rilpivirine
Medicine
Virology
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1029. Long-Term Patient Adherence and Management of Treatment Interruptions With Long-Acting Injectable Cabotegravir + Rilpivirine for Maintenance Therapy in Phase IIb/III Studies
2020
Open Forum Infectious Diseases
Paula Teichner
Sterling Wu
Feifan Zhang
David Dorey
Ronald D' Amico
Sandy Griffith
Kenneth Sutton
Cynthia C McCoig
Ojesh R Upadhyay
Joseph W. Polli
David A. Margolis
Rodica Van Solingen-Ristea
Kati Vandermeulen
William Spreen
Parul Patel
Show All
Source
Cite
Save
Citations (1)
1021. HIV-1 RNA Blips and Low-Level Replication During Phase III/IIIb Cabotegravir + Rilpivirine Long-Acting Studies Are Similar to Oral 3-Drug Therapy and Not Associated with Week 48 Virologic Outcome
2020
Open Forum Infectious Diseases
Christine L. Talarico
Sterling Wu
Ojesh R Upadhyay
Marty St. Clair
Veerle Van Eygen
Krischan J Hudson
Sandy Griffith
Conn M. Harrington
Jan van Lunzen
David A. Margolis
William Spreen
Show All
Source
Cite
Save
Citations (1)
1